慢性乙型肝炎治疗的挑战与希望:乙型肝炎表面抗原vs人体免疫
张学秀,徐向升,张政,王福生
摘要(Abstract)：
<正>乙型肝炎表面抗原(HBsAg)是诊断乙型肝炎病毒(HBV)感染的经典标志物,1963年由Blumberg教授首先在澳大利亚土著人的血清中发现,开始被称为澳大利亚抗原(澳抗,Au Ag),于1974年被正式命名为HBsAg[1,2]。HBsAg的发现具有里程碑的意义,Blumberg教授并因此项发现荣获了诺贝尔医学或生理学奖。距HBsAg的发现至今已经有50年的历史,最初其仅被应用于诊
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 张学秀,徐向升,张政,王福生
参考文献(References)：
- [1]Prince AM.An antigen detected in the blood during theincubation period of serum hepatitis[J].Proc Natl Acad Sci U SA,1968,60(3):814-821.
- [2]Blumberg BS,Alter HJ,Visnich S.A"new"antigen in leukemiasera[J].J Am Med Assoc,1965,191:541-546.
- [3]Das A,Hoare M,Davies N,et al.Functional skewing of theglobal CD8 T cell population in chronic hepatitis B virusinfection[J].J Exp Med,2008,205(9):2111-2124.
- [4]Zhang JY,Zhang Z,Lin F,et al.Interleukin-17-producingCD4(+)T cells increase with severity of liver damage inpatients with chronic hepatitis B[J].Hepatology,2010,51(1):81-91.
- [5]Milich DR,Chen MK,Hughes JL,et al.The secreted hepatitisB precore antigen can modulate the immune response to thenucleocapsid:a mechanism for persistence[J].J Immunol,1998,160(4):2013-2021.
- [6]Chen MT,Billaud JN,S llberg M,et al.A function of thehepatitis B virus precore protein is to regulate the immuneresponse to the core antigen[J].Proc Natl Acad Sci U S A,2004,101(41):14913-14918.
- [7]Van der Molen RG,Sprengers D,Binda RS,et al.Functionalimpairment of myeloid and plasmacytoid dendritic cellsof patients with chronic hepatitis B[J].Hepatology,2004,40(3):738-746.
- [8]Nguyen T,Thompson AJ,Bowden S,et al.Hepatitis B surfaceantigen levels during the natural history of chronic hepatitis B:a perspective on Asia[J].J Hepatol,2010,52(4):508-513.
- [9]Jaroszewicz J,Calle Serrano B,Wursthorn K,et al.HepatitisB surface antigen(HBsAg)levels in the natural history ofhepatitis B virus(HBV)-infection:a European perspective[J].JHepatol,2010,52(4):514-522.
- [10]Rehermann B,Nascimbeni M.Immunology of hepatitis B virusand hepatitis C virus infection[J].Nat Rev Immunol,2005,5(3):215-229.
- [11]Seto WK,Wong DK,Fung J,et al.Reduction of hepatitis Bsurface antigen levels and HBsAg seroclearance in chronichepatitis B patients receiving 10 years of nucleoside analoguetherapy[J].Hepatology,2013,[Epub ahead of print].
- [12]Chan HL,Wong VW,Wong GL,et al.A longitudinal study onthe natural history of serum hepatitis B surface antigen changesin chronic hepatitis B[J].Hepatology,2010,52(4):1232-1241.
- [13]Chan HL,Wong GL,Tse CH,et al.Viral determinants ofhepatitis B surface antigen seroclearance in hepatitis B eantigen-negative chronic hepatitis B patients[J].J Infect Dis,2011,204(3):408-414.
- [14]Kondo Y,Asabe S,Kobayashi K,et al.Recovery of functionalcytotoxic T lymphocytes during lamivudine therapy byacquiring multi-specificity[J].J Med Virol,2004,74(3):425-433.
- [15]Kondo Y,Ueno Y,Kobayashi K,et al.Hepatitis B virusreplication could enhance regulatory T cell activity byproducing soluble heat shock protein 60 from hepatocytes[J].JInfect Dis,2010,202(2):p.202-213.
- [16]Reignat S,Webster GJ,Brown D,et al.Escaping high viral loadexhaustion:CD8 cells with altered tetramer binding in chronichepatitis B virus infection[J].J Exp Med,2002,195(9):1089-1101.